Plastic fantastic

Article

As always, there is a steep learning curve when dealing with new technologies but it is clear that outcomes with AlphaCor are continuing to improve

How is it implanted?

The 'standard' procedure, developed during clinical trials, involves an extensive half-thickness incision 1.5 mm posterior to the limbus, through 180°, extended to create a central lamellar corneal pocket of 7.5 mm diameter open to the superior limbus. This allows access for a sharp skin biopsy punch, initially 3.0 mm, now generally 3.5 mm in diameter, used to enter the anterior chamber. The large incision is required to allow access for the trephine, but has disadvantages including significant peri-limbal disturbance, dissection over the old PK wound and a need to place a mattress suture to appose the lamellae adjacent to the device's upper edge, to prevent migration, prior to closing the scleral wound.

Trial & error

About two years ago there was a trend towards trying to reduce the incision length by using a 'low profile trephine' that obviated the need for a wide exposure to allow posterior stromal trephination. After extensive evaluation, it was found that the technique was often technically difficult, with the prototype trephines insufficiently sharp and scissors required to complete the posterior opening. This method is not currently used.

Lessons learned

There has been some interest in using femtosecond lasers to create the lamellar pocket dissection and entry wound. Evidence is currently limited but there are further studies planned which hope to clarify the benefits of its use.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
Dr Adam Muzychuk discusses his ASCRS presentation
© 2024 MJH Life Sciences

All rights reserved.